So thats some good stuff thank you for posting this in the advanced fourm ...so a little futher down on that link you post was this info....................Licensed and controlled cultivation....'' Clonal propagation does not involve genetic modification. """"
GW is licensed by the UK Home Office. Cultivation of GW's first Cannabis plants began in August 1998. Selected seedlings are maintained as clones. Clones are genetically identical, thus ensuring that the ratio of plant constituents is fixed within narrow limits. Clonal propagation does not involve genetic modification.
GW's botanical research team continues to develop new chemotypes. These will produce the raw material bases for future pharmaceutical research.
GW's Cannabis plants are grown in highly secure computer-controlled glasshouses. All aspects of the growing climate, including temperature, air change and photoperiod, are computer-controlled and the plants are grown without the use of pesticides. Careful control of the growing environment ensures that GW’s plant material is grown to very strict pharmaceutical standards and that growth is phased to ensure continuity of supply.
Cultivation capability has been increased to cater both for commercial supply of our first product Sativex® and research quantities of novel chemotypes for the production of other medicines. Pharmaceutical production capacity has also been scaled up, both in-house and through external contractors, to supply tens of thousands of patients.
High levels of chemical consistency are important in applications made to medical regulatory authorities. Routine laboratory analysis demonstrates that GW’s botanical raw materials meet strict specifications of quality.
